Association of an immunoscore with survival of stage III colon cancer (CC) patients treated with adjuvant FOLFOX (Alliance N0147)
   Google Scholar   
Citation:
J Clin Oncol vol 35 (15 suppl) abstr 3579
Meeting Instance:
ASCO 2017
Year:
2017
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
2802   3167  
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
GI    
Pharmas:
Sanofi, Eli Lilly  
Grants:
U10CA180821, U10CA180882  
Corr. Author:
 
Authors:
                           
Networks:
LAPS-IL036, LAPS-MN026, LAPS-OH007, MCRC   
Study
NCCTG-N0147
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: